4 patents
Utility
Microbial-based Compositions for Systemic Inflammation Control
30 Nov 23
Compositions containing live cultures of 11 separately isolated bacterial strains (the bacterial consortium containing all 11 strains designated GUT-108) are provided for treating conditions of systemic inflammation including, to name a few, Inflammatory Bowel Diseases, type-2 diabetes, metabolic syndrome and obesity, and aging-related conditions of chronic inflammation.
Daniel van der Lelie, Safiyh Taghavi
Filed: 14 Oct 21
Utility
Rational design of microbial-based biotherapeutics
7 Nov 23
Methods are provided for the rational design of stable communities of microbes for benefiting the health of a host organism, including human and/or animal health.
Daniel van der Lelie, Safiyh Taghavi
Filed: 3 Oct 19
Utility
Rational Design of Microbial-based Biotherapeutics
22 Jan 20
Methods are provided for the rational design of stable communities of microbes for benefiting the health of a host organism, including human and/or animal health.
Daniel van der Lelie, Safiyh Taghavi
Filed: 2 Oct 19
Utility
Immune Response Modulation Using Live Biotherapeutics, for Conditions Such As Allergy Desensitization
15 Jan 20
Provided herein are compositions (e.g., probiotic, pharmaceutical, etc.) comprising one or more strains of non-Clostridia class bacteria and methods of use thereof for allergen desensitization.
Jack A. GILBERT, Daniel van der LELIE, Safiyh TAGHAVI
Filed: 21 Sep 17
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first